-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Transplant in ALL: Who, When, and How?

Program: Education Program
Session: Adult ALL Advancements: Optimizing Cure in 2024
Hematology Disease Topics & Pathways:
Research, Clinical trials, Clinical Research, Education, Real-world evidence, Measurable Residual Disease
Monday, December 9, 2024, 2:45 PM-4:00 PM

Partow Kebriaei, MD

MD Anderson Cancer Center, Houston, TX

Disclosures: Kebriaei: Jazz Pharmaceuticals: Consultancy, Honoraria; Pfizer: Consultancy, Honoraria.

See more of: Adult ALL Advancements: Optimizing Cure in 2024
See more of: Education Program
<< Previous Presentation | Next Presentation